CSF3 and neuropathy: Additionally, in diabetic patients with neuropathy and vascular complications, G-CSF stimulation resulted in a decrease in PB SP levels (Fig. 7d, p < 0.01 vs non-diabetic individuals, p < 0.05 vs diabetes without complications).